Navigation Links
Experimental Insomnia Drug Shows Promise
Date:11/28/2012

By Amy Norton
HealthDay Reporter

WEDNESDAY, Nov. 28 (HealthDay News) -- A new insomnia drug helped people get a bit more shut-eye in a lab study, researchers report.

The drug, known as suvorexant, is being developed by Merck Research Laboratories, which funded and conducted the study. The medication is not available yet, but the U.S. Food and Drug Administration is reviewing it for possible approval, the researchers said.

In the United States, about 10 percent of people say they have chronic insomnia, according to the U.S. Centers for Disease Control and Prevention. There are sleep aids on the market, but they do not work for everyone and they can have side effects that include sleepwalking, daytime drowsiness and confusion.

Suvorexant works differently from those drugs, zeroing in on specific brain chemicals involved in the ability to sleep, explained study author Dr. William Herring, executive director of clinical research at Merck.

The study, published online Nov. 28 and in the Dec. 4 print issue of the journal Neurology, included 254 healthy adults with primary insomnia, which means it wasn't caused by an underlying physical or mental health problem.

All of the patients spent four weeks on one of four doses of suvorexant and another four weeks on placebo pills. They had their sleep monitored in a sleep lab on their first night with each treatment, and then came back again after four weeks.

Overall, Herring's team found, people slept better with the drug, although the improvement was not dramatic.

At the outset, when patients spent eight hours in bed, they were typically asleep for 66 percent of that time. One day on suvorexant boosted that by anywhere from 5 percent to 13 percent, relative to the placebo. Between 21 and 37 fewer minutes were spent awake during those sleep periods.

There was still a benefit four weeks later. One expert pointed out, however, that the
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Experimental Dengue Vaccine Shows Some Success
2. Standard chemotherapy provides higher survival rate than experimental in lung cancer patients
3. Cancer turns off important immune cells, complicating experimental vaccine therapies
4. Experimental Drug May Cut Severe Asthma Attacks: Study
5. Experimental Drug Suppresses Appetite in Mice: Study
6. Experimental Chemical Helps Blind Mice See
7. Experimental drug may extend therapeutic window for stroke
8. Fertility preservation with cryopreservation of ovarian tissue: from experimental to mainstream
9. Content Writing King Announces Cancellation Of Experimental Video Creation Process For Their Article Marketing Website
10. Experimental Vaccine Seems to Stop Nicotine Addiction in Mice
11. Experimental drug improves muscle strength among male cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Insomnia Drug Shows Promise
(Date:6/19/2013)... 2013) In early April, senior leaders from medical, ... Connecticut, to discuss one question: how can first responders ... , The preliminary results of this discussion are now ... The Hartford Consensus ," a concept paper published in ... of Trauma and Acute Care Surgery , official ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Effective Environmental Services ... of new websites. These online links are devoted to a ... Tank cleaner, Organic Odor Control Mold Magician and others. , ... fish and animals in the water as well as living ... sludge buildup that can accumulate at the bottom of a ...
(Date:6/19/2013)... Ky. (PRWEB) June 19, 2013 Dental ... during sedation because from minor to moderate sedation, a ... Oregon Board of Dentistry is the latest to update ... moderate and deep sedation in an effort to increase ... the Oregon Dental Practice Act goes into effect July ...
(Date:6/19/2013)... Brightree LLC , the leading provider of cloud-based ... care industry, has been ranked for the first time - ... (HCI 100) list. This prestigious list features the top ... revenue during the last fiscal year. Since 2005, Brightree’s revenue ... the company has built its organization to more than 500 ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 At a Travel ... positive changes and growth that has occurred over the last ... club. , Shuman said, "Travel Services has added vendors, lowered ... beyond belief. Membership is up, even in the tough ... the demands of members." , Having been in the Travel ...
Breaking Medicine News(10 mins):Health News:Hartford consensus aims to improve survival after mass shootings 2Health News:Effective Environmental Services Launch New Websites to Serve Customers 2Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 2Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 3Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2
... 8, 2011 - The Sea Grant programs of Connecticut ... grants valued at $1,130,832 to six projects that will look ... health of Long Island Sound, a water body designated by ... , Research results from five two-year projects and a one-year ...
... NC A UNC study released this week in the ... of squamous cell carcinoma of the oral tongue in young ... decades. A team of researchers from UNC Lineberger ... Surveillance, Epidemiology and End Results (SEER) database and found that, ...
... News) -- The percentage of personal bankruptcies caused by ... since Massachusetts began requiring people to buy health insurance ... challenges the Obama administration,s claim that medical bankruptcies will ... is largely patterned after the Massachusetts law, according to ...
... 2011 issue of the journal Heath Affairs ... implemented and tested by researchers and clinicians from Indiana ... Geriatric Resources for Assessment and Care of Elders (GRACE) ... lower income, older adults. GRACE is now in use ...
... physician-scientists at University Hospitals (UH) Case Medical Center are ... an early stage, aggressive type of breast cancer. ... of Breast Cancer Research at UH Case Medical Center,s ... breast cancer. Patients with this form of breast ...
... This release is available in Spanish and ... found to be 2.3-fold higher among Muslim adolescents than among ... the former group. Finally, as a general conclusion, an average ... disorder, and 15% suffers body dissatisfaction. These were the conclusions ...
Cached Medicine News:Health News:Sea grant awards more than $1.1 million for research under EPA's Long Island Sound study 2Health News:Sea grant awards more than $1.1 million for research under EPA's Long Island Sound study 3Health News:UNC study finds oral tongue cancer increasing in young, white females 2Health News:Mass. Health Reform Hasn't Halted Medical Bankruptcies 2Health News:Aging with grace: In-home assessments lead to better care, lower health costs 2Health News:Aging with grace: In-home assessments lead to better care, lower health costs 3Health News:Novel clinical trial aims to reduce recurrence of aggressive breast cancer 2Health News:Eating disorders and body dissatisfaction is double in Muslim teenagers than in Christian 2
(Date:6/19/2013)... , June 19, 2013  This year alone, The ... 300 research projects with one goal in mind: Discovering ... "Team In Training" (TNT), a flagship LLS fundraising campaign ... program, is marking its landmark 25 th anniversary. ... $875 million in research to discover and deliver breakthrough ...
(Date:6/19/2013)... YORK , June 19, 2013 ... brand new infographic summary of the results from ... a third of all respondents stated that CROs would be ... 50% of respondents will be running 6 or more clinical ... with the Clinical Trial Supply USA ...
(Date:6/18/2013)... YORK , June 18, 2013  Intercept Pharmaceuticals, ... biopharmaceutical company focused on the development and commercialization of ... today announced the pricing of an underwritten public offering ... public offering price of $33.01 per share.  In addition, ... purchase up to an additional 259,500 shares of common ...
Breaking Medicine Technology:Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 2Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 3Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 4Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 5Pharma IQ Presents the Latest Trends in Clinical Trial Supply 2Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
... PLAINS, N.Y., AUG. 2 Two major studies,published today ... doctors,better identify pregnant women at risk for preterm delivery ... Foundation said today. In one large multi-center trial ... (most of whom had no prior history of preterm ...
... - Access to Large Population of Glioblastoma Patients Expected ... Phase ll Study of Promising New Approach -, ... PPHM ), a clinical stage biopharmaceutical,company developing targeted monoclonal ... infection, today announced that the first,patient has been administered ...
Cached Medicine Technology:Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit 2Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India 2Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India 3Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India 4
... Steerability - Use the Attain Prevail's ... catheters and guide wires, to obtain the ... Inject contrast media for improved visualization of ... needed with tip deflection. Telescoping - ...
Attain™ Left-heart Lead Options to Fit Your Patient's Anatomy. Navigate moderately to greatly angled veins with high tortuosity....
... Mosaic, the third generation tissue valve from ... tissue valve available. The Mosaic valve builds ... and is an excellent choice for patients ... with a tissue valve. For more than ...
... Mitral bioprosthesis is a portrait ... based on 25 years of ... makes it an excellent choice ... replacement--particularly elderly patients and those ...
Medicine Products: